Want to see JP:6368 full AI Analyst Report?
6368 Stock Chart & Stats
¥13385.00
-¥140.00(-0.92%)
At close: 4:00 PM EDT
¥13385.00
-¥140.00(-0.92%)
Day’s Range― - ―
52-Week Range¥2,152.00 - ¥4,029.00
Previous CloseN/A
Volume368.30K
Average Volume (3M)1.24M
Market Cap
¥509.50B
Enterprise Value¥759.04B
Total Cash (Recent Filing)¥27.84B
Total Debt (Recent Filing)¥37.36B
Price to Earnings (P/E)18.0
Beta1.89
Next Earnings
Nov 02, 2026EPS Estimate
32.55Next Dividend Ex-DateN/A
Dividend Yield9.76%
Share Statistics
EPS (TTM)122.64
Shares Outstanding231,798,500
10 Day Avg. Volume1,113,260
30 Day Avg. Volume1,244,743
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)4.38
Price to Sales (P/S)3.52
P/FCF Ratio21.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)134.39
Revenue Forecast (FY)¥203.90B
Bulls Say, Bears Say
Bulls Say
Margin ExpansionSustained expansion in gross and net margins indicates that Organo has materially improved its earnings economics over several years. This strengthens internal funding capacity, supports resilience against cost pressure, and suggests profitability can remain a durable competitive advantage if operating discipline continues.
Consistent Revenue GrowthMulti-year revenue growth demonstrates continued demand for Organo’s water-treatment systems and services across commercial and industrial applications. Although the latest pace is slower, a sustained upward sales trajectory provides a durable base for recurring investment, customer expansion, and future profit generation.
Strong Recent Cash GenerationStrong recent operating and free cash flow, combined with high free-cash-flow conversion relative to net income, indicates generally sound earnings quality. This gives Organo meaningful capacity to fund operations, support investment, and manage obligations without relying excessively on external financing.
Bears Say
Recent Debt IncreaseThe recent increase in borrowing adds a lasting constraint to financial flexibility even though leverage remains manageable. Organo will need continued earnings and cash-flow strength to keep debt risk contained, while higher obligations may limit room for investment or shareholder distributions during weaker periods.
Historically Volatile Cash FlowPast periods of negative operating and free cash flow show that reported profitability has not translated into consistent cash generation across the full cycle. This creates execution and working-capital timing risk, making future investment capacity and debt management more dependent on sustained recent performance.
Moderating Revenue GrowthSlower recent top-line growth may indicate a maturing growth cycle or tougher comparisons after stronger expansion in prior years. If this moderation persists, it could reduce operating leverage, limit the pace of future earnings growth, and make margin improvements more important to overall returns.
6368 FAQ
What was Organo Corp.’s price range in the past 12 months?
Organo Corp. lowest stock price was ¥2152.00 and its highest was ¥4029.00 in the past 12 months.
What is Organo Corp.’s market cap?
Organo Corp.’s market cap is ¥509.50B.
When is Organo Corp.’s upcoming earnings report date?
Organo Corp.’s upcoming earnings report date is Nov 02, 2026 which is in 2 days.
How were Organo Corp.’s earnings last quarter?
Organo Corp. released its earnings results on Aug 03, 2026. The company reported ¥14.946 earnings per share for the quarter, missing the consensus estimate of ¥26.844 by -¥11.898.
Is Organo Corp. overvalued?
According to Wall Street analysts Organo Corp.’s price is currently Overvalued.
Does Organo Corp. pay dividends?
Organo Corp. pays a Semiannually dividend of ¥22 which represents an annual dividend yield of 9.76%. See more information on Organo Corp. dividends here
What is Organo Corp.’s EPS estimate?
Organo Corp.’s EPS estimate is 32.55.
How many shares outstanding does Organo Corp. have?
Organo Corp. has 231,798,500 shares outstanding.
What happened to Organo Corp.’s price movement after its last earnings report?
Organo Corp. reported an EPS of ¥14.946 in its last earnings report, missing expectations of ¥26.844. Following the earnings report the stock price went down -0.238%.
Which hedge fund is a major shareholder of Organo Corp.?
Currently, no hedge funds are holding shares in JP:6368
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Organo Corp.
Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.
Technical Analysis
Kurita Water Industries
―
METAWATER Co
―
Takuma Co
―
Mitsubishi Kakoki Kaisha,Ltd.
―
Hitachi Zosen Corporation
―
